|
Q2 FY2027
As of Jul 4, 2026
|
Q1 FY2027
As of Apr 4, 2026
|
Q4 FY2026
As of Jan 3, 2026
|
Q3 FY2026
As of Sep 27, 2025
|
Q2 FY2026
As of Jun 28, 2025
|
Q1 FY2026
As of Mar 29, 2025
|
Q4 FY2025
As of Dec 28, 2024
|
Q3 FY2025
As of Sep 28, 2024
|
Q2 FY2025
As of Jun 29, 2024
|
Q1 FY2025
As of Mar 30, 2024
|
Q4 FY2024
As of Dec 30, 2023
|
Q3 FY2024
As of Sep 30, 2023
|
Q2 FY2024
As of Jul 1, 2023
|
Q1 FY2024
As of Apr 1, 2023
|
Q4 FY2023
As of Dec 31, 2022
|
Q3 FY2023
As of Oct 1, 2022
|
Q2 FY2023
As of Jul 2, 2022
|
Q1 FY2023
As of Apr 2, 2022
|
Q4 FY2022
As of Jan 1, 2022
|
Q3 FY2022
As of Oct 2, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $3.5 and $1.4 | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Other Receivable - Sale of Business | ||||||||||||||||||||
| Assets of business held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and shareholders' equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||||
| Other accrued expenses and current liabilities | ||||||||||||||||||||
| Current portion of long-term non-revolving debt, net | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Liabilities of business held for sale | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Revolving line of credit | ||||||||||||||||||||
| Long-term non-revolving debt, net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Note 15 - Commitments and contingencies | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Preferred stock, par value $0.001, 2.0 shares authorized, no shares issued or outstanding | ||||||||||||||||||||
| Common stock, par value $0.001, 100.0 shares authorized, 33.5 and 33.4 shares issued; 33.1 and 33.1 outstanding at July 4, 2026 and January 3, 2026, respectively | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, at cost, 0.5 and 0.3 shares, respectively | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
